Back to all papers

ESR Essentials: lung cancer screening with low-dose CT-practice recommendations by the European Society of Thoracic Imaging.

Authors

Revel MP,Biederer J,Nair A,Silva M,Jacobs C,Snoeckx A,Prokop M,Prosch H,Parkar AP,Frauenfelder T,Larici AR

Affiliations (17)

  • Department of Radiology, Cochin Hospital, Université Paris Cité, Paris, France. [email protected].
  • Department of Diagnostic and Interventional Radiology, University Hospital of Heidelberg, Heidelberg, Germany.
  • Translational Lung Research Center Heidelberg (TLRC), Member of the German Lung Research Center (DZL), Heidelberg, Germany.
  • Faculty of Medicine, University of Latvia, Riga, Latvia.
  • Faculty of Medicine, Christian-Albrechts-Universität zu Kiel, Kiel, Germany.
  • Department of Radiology, University College London Hospital, London, UK.
  • Division of Medicine-Respiratory Medicine, University College London, London, UK.
  • Scienze Radiologiche, Department of Medicine and Surgery (DiMeC), University of Parma, Parma, Italy.
  • Department of Medical Imaging, Radboud University Center, Nijmegen, The Netherlands.
  • Department of Radiology, Antwerp University Hospital, Edegem, Belgium.
  • Department of Radiology, University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
  • Department of Radiology, Haraldsplass Deaconess Hospital, Bergen, Norway.
  • Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway.
  • Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Department of Radiological and Hematological Sciences, Catholic University of the Sacred Heart, Rome, Italy.
  • Department of Diagnostic Imaging and Oncological Radiotherapy, Advanced Radiology Center, "A. Gemelli" University Polyclinic Foundation IRCCS, Rome, Italy.

Abstract

Low-dose CT screening for lung cancer reduces the risk of death from lung cancer by at least 21% in high-risk participants and should be offered to people aged between 50 and 75 with at least 20 pack-years of smoking. Iterative reconstruction or deep learning algorithms should be used to keep the effective dose below 1 mSv. Deep learning algorithms are required to facilitate the detection of nodules and the measurement of their volumetric growth. Only large solid nodules larger than 500 mm<sup>3</sup> or those with spiculations, bubble-like lucencies, or pleural indentation and complex cysts should be investigated further. Short-term follow-up at 3 or 6 months is required for solid nodules of 100 to 500 mm<sup>3</sup>. A watchful waiting approach is recommended for most subsolid nodules, to limit the risk of overtreatment. Finally, the description of additional findings must be limited if LCS is to be cost-effective. KEY POINTS: Low-dose CT screening reduces the risk of death from lung cancer by at least 21% in high-risk individuals, with a greater benefit in women. Quality assurance of screening is essential to control radiation dose and the number of false positives. Screening with low-dose CT scans detects incidental findings of variable clinical relevance, only those of importance should be reported.

Topics

Journal ArticleReview

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.